Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
604
Recruiting Now
604
Top Conditions in Phase 1
NCT05032105 Phase 1
Recruiting
The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-O...
Condition
Anxiety
Enrollment
10 pts
Location
United States
Sponsor
Ohio State University
NCT06441994 Phase 1
Recruiting
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cance...
Condition
Prostate Cancer
Enrollment
15 pts
Location
Japan
Sponsor
Osaka University
NCT06105931 Phase 1
Recruiting
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
Condition
type1diabetes
Enrollment
15 pts
Location
United States
Sponsor
Yale University
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06644118 Phase 1
Recruiting
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Mye...
Condition
Multiple Myeloma
Enrollment
58 pts
Location
China
Sponsor
Zhejiang University
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT06646627 Phase 1
Recruiting
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant ...
Condition
Ovarian Cancer
Enrollment
48 pts
Location
United States
Sponsor
Stanford University
NCT06609083 Phase 1
Recruiting
Effect of Cannabis on Cigarette Use Behavior
Condition
Cannabis Use
Enrollment
100 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05661201 Phase 1
Recruiting
NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors
Condition
Solid Tumor
Enrollment
24 pts
Location
United States
Sponsor
Georgetown University
NCT05451251 Phase 1
Recruiting
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
Condition
Trigeminal Neuralgia
Enrollment
6 pts
Location
Canada
Sponsor
Université de Sherbrooke
NCT05333302 Phase 1
Recruiting
Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymp...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
10 pts
Location
Belarus
Sponsor
Belarusian Research Center for
NCT07349537 Phase 1
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06587295 Phase 1
Recruiting
Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tum...
Condition
Advanced Solid Tumor
Enrollment
40 pts
Location
Singapore
Sponsor
National Cancer Centre, Singap
NCT06049095 Phase 1
Recruiting
A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orall...
Condition
Healthy
Enrollment
204 pts
Location
New Zealand
Sponsor
Latigo Biotherapeutics
NCT06752746 Phase 1
Recruiting
A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunog...
Condition
Polycythemia Vera
Enrollment
108 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience
NCT07006688 Phase 1
Recruiting
A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and...
Condition
IDH1-Mutated Malignancies
Enrollment
30 pts
Location
United States, Australia, Brazil
Sponsor
Servier Bio-Innovation LLC
NCT07055854 Phase 1
Recruiting
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Bre...
Condition
Gynecologic Cancers
Enrollment
60 pts
Location
United States
Sponsor
Oregon State University
NCT06748651 Phase 1
Recruiting
Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Join...
Condition
Temporomandibular Joint Osteoarthritis
Enrollment
6 pts
Location
Israel
Sponsor
Dr. Amit Druyan
NCT06446531 Phase 1
Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk
Condition
Pre-Diabetes
Enrollment
64 pts
Location
United States
Sponsor
The University of Texas Health
NCT07214961 Phase 1
Recruiting
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration ...
Condition
Prostate Cancer (CRPC)
Enrollment
80 pts
Location
United States
Sponsor
ARTBIO Inc.
NCT06216041 Phase 1
Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H...
Condition
Nonalcoholic Steatohepatitis (NASH)
Enrollment
138 pts
Location
China
Sponsor
Changchun Intellicrown Pharmac
NCT06839105 Phase 1
Recruiting
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients W...
Condition
Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Enrollment
214 pts
Location
China
Sponsor
Shanghai Junshi Bioscience Co.
NCT06651866 Phase 1
Recruiting
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagno...
Condition
Acute Myeloid Leukemia
Enrollment
18 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT06896422 Phase 1
Recruiting
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCL...
Condition
Non-Small Cell Lung Cancer
Enrollment
80 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT06368895 Phase 1
Recruiting
Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Tre...
Condition
Hepatic Encephalopathy
Enrollment
60 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers